Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

2.
3.

Structure of the active domain of the herpes simplex virus protein ICP47 in water/sodium dodecyl sulfate solution determined by nuclear magnetic resonance spectroscopy.

Pfänder R, Neumann L, Zweckstetter M, Seger C, Holak TA, Tampé R.

Biochemistry. 1999 Oct 12;38(41):13692-8.

PMID:
10521276
4.

Herpes simplex virus type 2 ICP47 inhibits human TAP but not mouse TAP.

Tomazin R, van Schoot NE, Goldsmith K, Jugovic P, Sempé P, Früh K, Johnson DC.

J Virol. 1998 Mar;72(3):2560-3.

5.

Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47.

Ahn K, Meyer TH, Uebel S, Sempé P, Djaballah H, Yang Y, Peterson PA, Früh K, Tampé R.

EMBO J. 1996 Jul 1;15(13):3247-55.

6.

Structure of the viral TAP-inhibitor ICP47 induced by membrane association.

Beinert D, Neumann L, Uebel S, Tampé R.

Biochemistry. 1997 Apr 15;36(15):4694-700.

PMID:
9109681
7.

Herpes simplex virus turns off the TAP to evade host immunity.

Hill A, Jugovic P, York I, Russ G, Bennink J, Yewdell J, Ploegh H, Johnson D.

Nature. 1995 Jun 1;375(6530):411-5.

PMID:
7760935
8.

A viral inhibitor of peptide transporters for antigen presentation.

Früh K, Ahn K, Djaballah H, Sempé P, van Endert PM, Tampé R, Peterson PA, Yang Y.

Nature. 1995 Jun 1;375(6530):415-8.

PMID:
7760936
9.

Inhibition of mouse TAP by immune evasion molecules encoded by non-murine herpesviruses.

Verweij MC, Ressing ME, Knetsch W, Quinten E, Halenius A, van Bel N, Hengel H, Drijfhout JW, van Hall T, Wiertz EJ.

Mol Immunol. 2011 Mar;48(6-7):835-45. doi: 10.1016/j.molimm.2010.12.008. Epub 2011 Feb 2.

10.

Characterization of porcine TAP genes: alternative splicing of TAP1.

García-Borges CN, Phanavanh B, Crew MD.

Immunogenetics. 2006 Jun;58(5-6):374-82. Epub 2006 Mar 23.

PMID:
16555068
11.
12.

A mechanism of viral immune evasion revealed by cryo-EM analysis of the TAP transporter.

Oldham ML, Hite RK, Steffen AM, Damko E, Li Z, Walz T, Chen J.

Nature. 2016 Jan 28;529(7587):537-40. doi: 10.1038/nature16506. Epub 2016 Jan 20.

13.
14.

Preventing vaccinia virus class-I epitopes presentation by HSV-ICP47 enhances the immunogenicity of a TAP-independent cancer vaccine epitope.

Raafat N, Sadowski-Cron C, Mengus C, Heberer M, Spagnoli GC, Zajac P.

Int J Cancer. 2012 Sep 1;131(5):E659-69. doi: 10.1002/ijc.27362. Epub 2012 Jan 3.

15.

Intracellular location, complex formation, and function of the transporter associated with antigen processing in yeast.

Urlinger S, Kuchler K, Meyer TH, Uebel S, Tampé R.

Eur J Biochem. 1997 Apr 15;245(2):266-72.

16.

Peptides induce ATP hydrolysis at both subunits of the transporter associated with antigen processing.

Chen M, Abele R, Tampé R.

J Biol Chem. 2003 Aug 8;278(32):29686-92. Epub 2003 May 30.

17.
18.
19.

Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP.

Tomazin R, Hill AB, Jugovic P, York I, van Endert P, Ploegh HL, Andrews DW, Johnson DC.

EMBO J. 1996 Jul 1;15(13):3256-66.

20.

A dual inhibition mechanism of herpesviral ICP47 arresting a conformationally thermostable TAP complex.

Herbring V, Bäucker A, Trowitzsch S, Tampé R.

Sci Rep. 2016 Nov 15;6:36907. doi: 10.1038/srep36907.

Supplemental Content

Support Center